Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Nutrients ; 15(5)2023 Mar 06.
Article in English | MEDLINE | ID: mdl-36904293

ABSTRACT

Type 2 diabetes mellitus (T2DM) is a major cause of morbidity and mortality, and it is a major risk factor for the early onset of cardiovascular diseases (CVDs). More than genetics, food, physical activity, walkability, and air pollution are lifestyle factors, which have the greatest impact on T2DM. Certain diets have been shown to be associated with lower T2DM and cardiovascular risk. Diminishing added sugar and processed fats and increasing antioxidant-rich vegetable and fruit intake has often been highlighted, as in the Mediterranean diet. However, less is known about the interest of proteins in low-fat dairy and whey in particular, which have great potential to improve T2DM and could be used safely as a part of a multi-target strategy. This review discusses all the biochemical and clinical aspects of the benefits of high-quality whey, which is now considered a functional food, for prevention and improvement of T2DM and CVDs by insulin- and non-insulin-dependent mechanisms.


Subject(s)
Cardiovascular Diseases , Diabetes Mellitus, Type 2 , Humans , Diabetes Mellitus, Type 2/prevention & control , Whey Proteins/therapeutic use , Cardiovascular Diseases/prevention & control , Blood Glucose/metabolism , Functional Food
2.
Phytother Res ; 28(10): 1423-46, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24831562

ABSTRACT

Many studies have shown that a large number of terpenoids and aromatic compounds contained in essential oils have significant anticancer activities, both on cell lines and on tumors in animals. The activity of these constituents is related to the activation of cell death (apoptosis) induced by the caspases proteins in cancer cells, with minor modifications of healthy cells. Many phenomena seem to occur, among which are as follows: overexpression and regulation of liver detoxification enzymes, changes in the membrane potential of cancer cells and mitochondria, production of free radicals in cancer cells, inhibition of angiogenesis, and modification of tumor-inducing genes. These active essential oil constituents appear to act synergistically with conventional chemotherapy and radiotherapy, and some clinical studies in humans are beginning to be realized. In this review, we discuss about the antitumoral activity of 13 essential oil components selected among the most studied in the literature, with a focus on their possible mode of action. We also report current data on the anticancer properties of several total essential oils.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Oils, Volatile/pharmacology , Plant Oils/pharmacology , Animals , Apoptosis/drug effects , Caspases/metabolism , Cell Death/drug effects , Cell Line, Tumor , Drug Synergism , Humans , Membrane Potential, Mitochondrial/drug effects , Membrane Potentials/drug effects , Neoplasms/drug therapy , Neoplasms/pathology
3.
Chem Biol Interact ; 190(1): 28-34, 2011 Mar 15.
Article in English | MEDLINE | ID: mdl-21216240

ABSTRACT

Numerous reactive oxygen species (ROS) and reactive carbonyl species (RCS) issuing from lipid and sugar oxidation are known to damage a large number of proteins leading to enzyme inhibition and alteration of cellular functions. Whereas studies in literature only focus on the reactivity of one or two of these compounds, we aimed at comparing in the same conditions of incubations (4 and 24h at 37°C) the effects of both various RCS (4-hydroxynonenal, 4-hydroxyhexenal, acrolein, methylglyoxal, glyoxal, malondialdehyde) and ROS (H2O2, AAPH) on the activity of key enzymes involved in cellular oxidative stress: superoxide dismutase (Cu,Zn-SOD), glutathione peroxidase (GPx), glutathione S-transferase (GST) and glucose-6-phosphate dehydrogenase (G6PDH). This was realized both in vitro on purified proteins and MIAPaCa-2 cells. Incubation of these enzymes with RCS resulted in a significant time- and concentration-dependent inhibition for both pure enzymes and in cell lysates. Among all RCS and ROS, hydroxynonenal (HNE) was observed as the most toxic for all studied enzymes except for SOD and is followed by hydrogen peroxide. At 100µM, HNE resulted in a 50% reduction of GPx, 56% of GST, 65% of G6PDH, and only 10% of Cu,Zn-SOD. Meanwhile it seems that concentrations used in our study are closer to biological conditions for ROS than for RCS. H2O2 and AAPH-induced peroxyl radicals may be probably more toxic towards the studied enzymes in vivo.


Subject(s)
Aldehydes/toxicity , Antioxidants/metabolism , Glutathione Transferase/metabolism , Oxidative Stress , Oxidoreductases/metabolism , Reactive Oxygen Species/toxicity , Acrolein/toxicity , Amidines/toxicity , Cell Line, Tumor , Glucosephosphate Dehydrogenase/metabolism , Glutathione Peroxidase/metabolism , Glyoxal/toxicity , Humans , Hydrogen Peroxide/toxicity , Malondialdehyde/toxicity , Pyruvaldehyde/toxicity , Superoxide Dismutase/metabolism
4.
Toxicol Appl Pharmacol ; 243(1): 1-12, 2010 Feb 15.
Article in English | MEDLINE | ID: mdl-20034506

ABSTRACT

Aldehydes such as acrolein are ubiquitous pollutants present in automobile exhaust, cigarette, wood, and coal smoke. Such aldehydes are also constituents of several food substances and are present in drinking water, irrigation canals, and effluents from manufacturing plants. Oral intake represents the most significant source of exposure to acrolein and related aldehydes. To study the effects of short-term oral exposure to acrolein on lipoprotein levels and metabolism, adult mice were gavage-fed 0.1 to 5 mg acrolein/kg bwt and changes in plasma lipoproteins were assessed. Changes in hepatic gene expression related to lipid metabolism and cytokines were examined by qRT-PCR analysis. Acrolein feeding did not affect body weight, blood urea nitrogen, plasma creatinine, electrolytes, cytokines or liver enzymes, but increased plasma cholesterol and triglycerides. Similar results were obtained with apoE-null mice. Plasma lipoproteins from acrolein-fed mice showed altered electrophoretic mobility on agarose gels. Chromatographic analysis revealed elevated VLDL cholesterol, phospholipids, and triglycerides levels with little change in LDL or HDL. NMR analysis indicated shifts from small to large VLDL and from large to medium-small LDL with no change in the size of HDL particles. Increased plasma VLDL was associated with a significant decrease in post-heparin plasma hepatic lipase activity and a decrease in hepatic expression of hepatic lipase. These observations suggest that oral exposure to acrolein could induce or exacerbate systemic dyslipidemia and thereby contribute to cardiovascular disease risk.


Subject(s)
Acrolein/toxicity , Dyslipidemias/chemically induced , Lipoproteins/blood , Acrolein/administration & dosage , Acrolein/pharmacology , Animals , Apolipoproteins E/genetics , Apolipoproteins E/metabolism , Dose-Response Relationship, Drug , Drug Administration Routes , Drug Administration Schedule , Gene Expression Regulation , Lipase/metabolism , Liver/drug effects , Liver/enzymology , Male , Mice , Mice, Inbred C57BL , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley
5.
J Pharmacol Exp Ther ; 331(2): 456-69, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19696094

ABSTRACT

Hemorrhagic cystitis and diffuse inflammation of the bladder, common side effects of cyclophosphamide (CY) treatment, have been linked to the generation of acrolein derived from CY metabolism. Metabolic removal of acrolein involves multiple pathways, which include reduction, oxidation, and conjugation with glutathione. Herein, we tested the hypothesis that glutathione S-transferase P (GSTP), the GST isoform that displays high catalytic efficiency with acrolein, protects against CY-induced urotoxicity by detoxifying acrolein. Treatment of wild-type (WT) and mGstP1/P2 null (GSTP-null) mice with CY caused hemorrhagic cystitis, edema, albumin extravasation, and sloughing of bladder epithelium; however, CY-induced bladder ulcerations of the lamina propria were more numerous and more severe in GSTP-null mice. CY treatment also led to greater accumulation of myeloperoxidase-positive cells and specific protein-acrolein adducts in the bladder of GSTP-null than WT mice. There was no difference in hepatic microsomal production of acrolein from CY or urinary hydroxypropyl mercapturic acid output between WT and GSTP-null mice, but CY induced greater c-Jun NH(2)-terminal kinase (JNK) and c-Jun, but not extracellular signal-regulated kinase or p38, activation in GSTP-null than in WT mice. Pretreatment with mesna (2-mercaptoethane sulfonate sodium) abolished CY toxicity and JNK activation in GSTP-null mice. Taken together, these data support the view that GSTP prevents CY-induced bladder toxicity, in part by detoxifying acrolein. Because polymorphisms in human GSTP gene code for protein variants differing significantly in their catalytic efficiency toward acrolein, it is likely that GSTP polymorphisms influence CY urotoxicity. In addition, pretreatment with dietary or nutrient inducers of GSTP may be of use in minimizing bladder injury in patients undergoing CY therapy.


Subject(s)
Antineoplastic Agents, Alkylating/toxicity , Cyclophosphamide/toxicity , Glutathione Transferase/genetics , Glutathione Transferase/physiology , Urinary Bladder Diseases/chemically induced , Urinary Bladder Diseases/genetics , Acetylcysteine/urine , Acrolein/metabolism , Animals , Antineoplastic Agents, Alkylating/metabolism , Blotting, Western , Chemical and Drug Induced Liver Injury/pathology , Cyclophosphamide/metabolism , Cystitis/chemically induced , Cystitis/pathology , Hemorrhage/chemically induced , Hemorrhage/pathology , Immunohistochemistry , In Situ Nick-End Labeling , Lipids/blood , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Organ Size/drug effects , Reverse Transcriptase Polymerase Chain Reaction , Urinary Bladder/pathology , Urinary Bladder Diseases/pathology
6.
Free Radic Biol Med ; 47(10): 1375-85, 2009 Nov 15.
Article in English | MEDLINE | ID: mdl-19682568

ABSTRACT

Quantification of 4-hydroxy-2-nonenal (HNE) bound to circulating proteins may prove to be useful in evaluating the role of this bioactive lipoperoxidation by-product in the pathogenesis of various diseases. Recently, we developed a quantitative gas chromatography-mass spectrometry (GCMS) assay of total protein-bound HNE (HNE-P) in blood after reduction with NaB(2)H(4) and cleavage with Raney nickel. Whereas it has been assumed that Raney nickel cleaves only Michael adducts of HNE to cysteine via a thioether bond (HNE-SP), results from this study demonstrate that our GCMS method also detects with precision picomoles of HNE adducts via nitrogen residues (HNE-NP). Specifically, evidence was obtained using various study models, including polyamino acids consisting of cysteine, lysine, and histidine and a biologically relevant molecule, albumin. Furthermore, we show that dinitrophenylhydrazine treatment before Raney nickel treatment can be used to discriminate and quantify the various HNE-P molecular species in plasma and blood samples from normal rats, which range between 0.15 and 3 pmol/mg protein or 10 to 600 nM. However, whereas HNE-SP predominated in whole blood, we detected HNE-NP only in plasma. We also identified another significant MS signal, which we attribute to protein-bound 1,4-dihydroxynonane (DHN-P) presumably formed from the enzymatic reduction of HNE-P. The distribution profile of all these species in plasma differed from that observed when physiologically relevant concentrations of albumin and HNE were incubated in vitro. Furthermore, interestingly, hypercholesterolemic rabbits showed higher plasma levels of HNE-NP, but not of DHN-P. Beyond documenting the presence of various types of HNE-P in circulating proteins, our results emphasize the importance of enzymatic mechanisms in situ as a factor determining their distribution in the various blood compartments under various conditions.


Subject(s)
Aldehydes/analysis , Blood Proteins/chemistry , Histidine/chemistry , Lysine/chemistry , Nickel/chemistry , Animals , Gas Chromatography-Mass Spectrometry , Male , Rabbits
7.
Int J Vitam Nutr Res ; 75(1): 11-8, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15830916

ABSTRACT

Assessment of the antioxidant activity of vitamins and other compounds is of interest in the understanding of their in vivo effects. In this study, we have investigated the activity of several lipid and water-soluble vitamins in human whole blood. Measurements were carried out using a biological test that enables the evaluation of both red blood cells and plasma resistance against free radical activity induced by 2,2'-azobis (2-amidinopropane)hydrochloride (AAPH). Antioxidant activity of vitamins has been determined by using the biological test versus chemical methods (chemiluminescence, DMPD radical). We have observed strong anti-oxidant potentials for vitamins B6 and B9 with biological tests, but not with chemical methods. At 10 microM, the vitamin B9 efficiency in inhibiting radical-induced red blood cell hemolysis was almost three times higher than vitamin C efficiency and two times higher than alpha-tocopherol efficiency. Antioxidant activity was not observed for vitamins B1 or B2, nor for retinol. The weak activity of beta-carotene still remains to be investigated particularly in relation to oxygen pressure. Our study demonstrated that the biological test is more useful than the chemical methods employed in this instance, for the evaluation of antioxidant capacity of lipophilic and putatively biologically active compounds.


Subject(s)
Antioxidants/pharmacology , Fluorescent Dyes , Luminescent Measurements/methods , Phenylenediamines , Vitamins/blood , Vitamins/pharmacology , Amidines/pharmacology , Antioxidants/metabolism , Ascorbic Acid/blood , Ascorbic Acid/pharmacology , Biological Assay , Caffeic Acids/blood , Caffeic Acids/pharmacology , Dose-Response Relationship, Drug , Hemolysis/drug effects , Humans , Oxidants/pharmacology , Reference Values , Solubility , Vitamin A/blood , Vitamin A/pharmacology , Vitamin B Complex/blood , Vitamin B Complex/pharmacology , alpha-Tocopherol/blood , alpha-Tocopherol/pharmacology , beta Carotene/blood , beta Carotene/pharmacology
8.
Biochim Biophys Acta ; 1621(1): 1-8, 2003 Apr 07.
Article in English | MEDLINE | ID: mdl-12667604

ABSTRACT

This study deals with the activity of various vitamins against the radical-mediated oxidative damage in human whole blood. We have used a biological method that allows both the evaluation of plasma and that of red blood cell resistance against the free radicals induced by 2,2'-azobis (2-amidinopropane) hydrochloride (AAPH). Spin trapping measures using mainly 5-(diethoxyphosphoryl)-5-methyl-1-pyrolline N-oxide nitrone (DEPMPO) were carried out under several conditions to identify the free radicals implicated in this test. Only the oxygenated-centred radical generated from AAPH was found highly reactive to initiate red blood cell lysis. With DEPMPO only alkoxyl radicals were observed and no evidence was found for alkylperoxyl radicals. The antioxidant activity of several lipid- and water-soluble vitamins has been assessed by the biological assay and through two chemical methods. We have noticed high antioxidant activities for tocopherols (in the order delta>gamma>alpha) in the biological test but not through chemical methods. At 1 microM, the delta-tocopherol efficiency in inhibiting radical-induced red blood cell hemolysis was three times as high as the alpha-tocopherol efficiency. For beta-carotene no significant activity even in whole blood was shown. Highly surprising antioxidant activities were observed for acid folic and pyridoxine, compared to ascorbic acid. At 10 microM, the effectiveness of folic acid was almost three times as high as vitamin C. The biological test seems clinically more relevant than most other common assays because it can detect several classes of antioxidants.


Subject(s)
Antioxidants/pharmacology , Blood , Erythrocytes/drug effects , Hemolysis/drug effects , Oxidants/analysis , Vitamins/pharmacology , Amidines/analysis , Antioxidants/chemistry , Electron Spin Resonance Spectroscopy , Endpoint Determination , Erythrocyte Membrane/drug effects , Erythrocytes/chemistry , Free Radical Scavengers , Free Radicals/chemistry , Luminescent Measurements , Oxygen , Spin Trapping , Vitamins/chemistry
9.
Environ Health Perspect ; 110(5): 479-86, 2002 May.
Article in English | MEDLINE | ID: mdl-12003751

ABSTRACT

Oxidative damage is increasingly recognized as playing an important role in the pathogenesis of several diseases such as cancer and cardiovascular diseases. Using a biologic test based on whole blood resistance to free-radical aggression, we sought to evaluate lifestyle factors that may contribute to the normal variability of the overall antioxidant status. We assessed this global antiradical defense capacity in 88 men and 96 women in relation to information on lifestyle obtained by questionnaire. In our relatively young, healthy population, we found a weak negative relation between male sex or aging and the resistance to oxidant stress. Among the factors studied, nonsmoking, vitamin and/or mineral supplementation, and regular physical activity were closely associated with an increased overall antioxidant capacity. Conversely, the antioxidant potential was negatively related to tobacco smoking; psychologic stress; alcohol consumption; moderate vegetable, low fruit, and low fish consumption; and, to a lesser extent, high natural ultraviolet light exposure. Thus, we were able to determine "unhealthy" and "healthy" lifestyle patterns that truly contributed to the variation of individual antioxidant capacity. We conclude that lifestyle determinants of cancer and cardiovascular risks were associated with a decreased overall antioxidant status as dynamically measured by means of a biologic test. Thus, the evaluation of the total human resistance against free-radical aggression, taking into account nutritional habits, lifestyle, and environmental factors, may be useful in preventive medicine as a precocious diagnosis to identify healthy subjects who are at risk for free-radical-mediated diseases.


Subject(s)
Antioxidants/pharmacology , Free Radicals/adverse effects , Health Status , Life Style , Oxidative Stress , Adult , Age Factors , Aged , Diet , Female , Hemolysis , Humans , Male , Middle Aged , Risk Assessment , Sex Factors , Smoking/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...